BioAge Labs (BIOA) Operating Income (2023 - 2026)

BioAge Labs has disclosed Operating Income across 4 years of filings, most recently posting -$25.4 million for Q1 2026.

• Operating Income for Q1 2026 came in at -$25.4 million, down 54.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$101.7 million (down 24.3% YoY), and the FY2025 annual result was -$92.8 million, down 18.65% from the prior year.
• Operating Income came in at -$25.4 million for Q1 2026 at BioAge Labs, up from -$28.4 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$9.9 million in Q3 2023 to a low of -$28.4 million in Q4 2025.
• The 4-year median for Operating Income is -$23.1 million (2025), against an average of -$20.0 million.
• Across the five-year window, Operating Income tumbled 150.33% in 2024 and climbed 6.51% in 2025, its largest moves.
• BioAge Labs' Operating Income stood at -$13.6 million in 2023, then plunged by 86.54% to -$25.4 million in 2024, then declined by 12.07% to -$28.4 million in 2025, then climbed by 10.72% to -$25.4 million in 2026.
• The last three Operating Income figures came in at -$25.4 million (Q1 2026), -$28.4 million (Q4 2025), and -$23.1 million (Q3 2025), per Business Quant data.